Physician profile
Brian P Betensky
NPI 1851553481
$411,563.34
in general payments reported to CMS, 2019-2025
32 companies · $119K in 2025
The $119K reported for 2025 was more than what 98% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $40K · 2021: $33K · 2022: $50K · 2023: $58K · 2024: $71K · 2025: $119K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $113K · Consulting Fee: $88K · Honoraria: $38K · Food and Beverage: $6,697 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,750 · Education: $70.00 · Travel and Lodging: $59.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $112,537.50 |
| Consulting Fee | $87,631.25 |
| Honoraria | $38,347.00 |
| Food and Beverage | $6,697.07 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,750.00 |
| Education | $70.00 |
| Travel and Lodging | $59.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114,475.92 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $93,177.74 | 2019-2025 | General - Ep, General - Brady, Rhythmia Mapping System |
| Elutia, INC. | $74,247.06 | 2019-2025 | Ecm Patch,Pouch |
| Medical Device Business Services, INC. | $56,700.00 | 2023-2025 | Carto 3 |
| Abbott Laboratories | $35,437.42 | 2019-2025 | Gallant, Allure, Aveir |
| Biosense Webster, INC. | $26,751.62 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Cardiva Medical, INC. | $5,596.62 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Janssen Pharmaceuticals, INC | $1,314.82 | 2019-2022 | |
| Medtronic, INC. | $1,222.75 | 2021-2025 | Linq II, Reveal Linq, Selectsecure |
| Novartis Pharmaceuticals Corporation | $524.25 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $326.23 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $309.35 | 2021-2025 | Verquvo |
| Amgen INC. | $284.29 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $243.53 | 2019-2025 | |
| Medtronic Vascular, INC. | $185.10 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acutus Medical, INC. | $103.57 | 2022-2023 | |
| Esperion Therapeutics, INC. | $100.43 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $70.80 | 2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.70 | 2019-2022 | |
| Cvrx, INC. | $65.07 | 2022-2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals, Ltd. | $52.75 | 2021-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $43.63 | 2024 | Amvuttra, Onpattro |
| Regeneron Healthcare Solutions, INC. | $39.89 | 2019-2025 | Evkeeza |
| Astrazeneca Pharmaceuticals Lp | $34.73 | 2021-2025 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $30.78 | 2024 | Arcalyst |
| Cordis US Corp. | $30.32 | 2025 | Mynx Control Venous |
| Amarin Pharma, INC. | $30.15 | 2021 | |
| Philips North America LLC | $27.50 | 2025 | Diagnostic Ecg Service |
| Heartflow, INC. | $26.10 | 2025 | |
| Novo Nordisk INC | $15.62 | 2023 | Ozempic, Rybelsus |
| Kestra Medical Technology Services, INC. | $12.85 | 2023 | Assure Wcd |
| Biotronik INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Betensky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.